新天药业：控股股东拟减持2.9962%

Group 1 - The controlling shareholder, Shanghai Xintian Zhiyao Biotechnology Co., Ltd., plans to reduce its holdings due to funding needs [1] - The reduction will occur from November 11, 2025, to February 10, 2026, through block trades and centralized bidding [1] - The total shares to be reduced amount to no more than 7.05 million shares, representing 2.9962% of the total share capital after buyback [1] Group 2 - The maximum number of shares to be reduced through block trades is 4.7 million, accounting for 1.9975% of the adjusted total share capital [1] - The maximum number of shares to be reduced through centralized bidding is 2.35 million, representing 0.9987% of the total share capital [1] - The minimum reduction price is set at 4.97 yuan per share, adjusted from the initial public offering price [1]